Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients with Newly Diagnosed Advanced Ovarian Cancer
Bradley J. Monk,Ignacio Romero,Whitney Graybill,Cristina Churruca,David M. O'Malley,Anja or Knudsen, Oi Wah Stephanie Yap,Jean-Francois Baurain,Peter G. Rose,Hannelore Denys,Sharad Ghamande,Carmela Pisano,Michel Fabbro, Elena Ioana Braicu,Paula M. Calvert,Amnon Amit,Emily Prendergast, Adekemi Taylor, Leila Kheibarshekan, Zhi-Yi Zhang,Stefan Zajic, Roxanne C. Jewell,Divya Gupta,Antonio Gonzalez-Martin Clinical Therapeutics（2024）
关键词
Niraparib,Ovarian cancer,PARP inhibitor,Population pharmacokinetics
AI 理解论文
溯源树
样例
